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EDITORIAL
International Thymic Malignancy Interest Group
Frank Detterbeck, MD,* Giuseppe Giaccone, MD,† Patrick Loehrer, MD,‡ Saul Suster, MD,§
and Cameron Wright, MD
Thymomas and thymic carcinomas are rare tumors that are complex, with issuesrelated to associated conditions, involved structures, understanding of the biology,
and definition of the optimal treatment. Currently, data stem from single centers, with
reports generally spanning many decades, and level 1 evidence is lacking. To make
progress in the treatment and understanding of these unique malignancies, there is a
need for an organized collaborative effort, which necessitates creation of an interna-
tional infrastructure.
To enhance international teamwork, the Foundation for Thymic Cancer Re-
search organized two meetings of many of the leaders in this field (in New York in
2007 and at MD Anderson in 2008). The Foundation is a patient and family
organization focused on both patient advocacy and promotion of research. These
meetings led to several collaborative initiatives and publications,1 including several
meta-analyses2,3 and NCCN guidelines for the management of thymic malignancies.4
These meetings also highlighted the need for greater infrastructure to foster true
prospective collaboration. A nucleus of individuals has developed this concept and
initiated the process. An initial focal point was to organize an international conference
devoted to thymic malignancies and the development of an international organization.
On August 20 and 21, 2009, the 1st International Conference for Thymic Malig-
nancies was convened in Bethesda, cosponsored by the National Cancer Institute and the
Foundation for Thymic Cancer Research. Proceedings of this meeting will be published
in a special monograph. This meeting also provided a broad forum to discuss the
formation of an international organization, which has been named the International
Thymic Malignancy Interest Group (ITMIG). This brief report summarizes the status of
this effort. Further information is also available at: www.itmig.org.
Several organizations have come forward in support of the development of
ITMIG, including the International Association for the study of Lung Cancer, the
European Society of Thoracic Surgeons, the European Association of Cardiothoracic
Surgery, and the Japanese Association for Research on the Thymus. ITMIG has
organized several workgroups to address initial projects. A meeting is planned in 2010
to formalize the organization of ITMIG and the structure for the continuation of
collaborative projects.
An organizational structure workgroup with broad international representation is
charged with drafting the formal structure of ITMIG. This includes further develop-
ment of the relationship with other organizations, with which ITMIG will work in very
close collaboration. A research committee is developing a list of research priorities
and a structure for evaluation of research proposals and to foster fundraising for
research. A database workgroup is developing a system for international data collec-
tion. This is done in collaboration with the International Association for the study
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of Lung Cancer staging committee, with one of the goals
being the eventual validation of a staging system for
thymic malignancies. A tissue banking workgroup is de-
veloping infrastructure to allow sharing of tissue resources
between institutions. Another workgroup is defining stan-
dard outcome measures for reporting of clinical experi-
ence. A process standards workgroup is defining standard
operating procedures for handling of surgical specimens
and reporting of operative and pathology results. Another
project involves developing a platform for greater interface
and crosseducation among pathologists to form a basis for
collaborative thought in dealing with pathology issues.
Each of these projects involves an initial workgroup to
lead the effort, but broad participation is sought. Individ-
uals interested in contributing to any of these projects are
encouraged to contact those involved through the ITMIG
website (www.itmig.org).
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